Inspira Technologies Oxy B.H.N. Ltd. (IINN): Price and Financial Metrics
GET POWR RATINGS... FREE!
IINN Stock Price Chart Interactive Chart >
IINN Price/Volume Stats
| Current price | $1.30 | 52-week high | $9.59 |
| Prev. close | $1.25 | 52-week low | $1.10 |
| Day low | $1.22 | Volume | 26,084 |
| Day high | $1.31 | Avg. volume | 918,676 |
| 50-day MA | $1.75 | Dividend yield | N/A |
| 200-day MA | $2.72 | Market Cap | 10.13M |
Inspira Technologies Oxy B.H.N. Ltd. (IINN) Company Bio
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Latest IINN News From Around the Web
Below are the latest news stories about Inspira Technologies OXY BHN Ltd that investors may wish to consider to help them evaluate IINN as an investment opportunity.
Inspira Technologies Applauded by Frost & Sullivan for Minimizing the Need for Invasive Mechanical Ventilation with Its Innovative Technology, the ART™ SystemFrost & Sullivan recently analyzed the European artificial respiratory market and, based on its findings, recognizes Inspira Technologies (Nasdaq: IINN/IINNW) with the 2021 Europe Technology Innovation Leadership Award. The company provides innovative medical technologies in the respiratory care industry. Inspira's ART system, a proprietary, early extracorporeal respiratory support system that elevates oxygen saturation levels, is designed to be a new standard of care as a second-line treatment |
Inspira Technologies Is Awarded the 2021 Frost & Sullivan Technology Innovation Leadership AwardInspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that it has been awarded the 2021 Europe Technology Innovation Leadership Award in the artificial respiratory market by Frost & Sullivan, a global research consulting firm with extensive experience in growth opportunities. The award recognizes Inspira Technologies for its innovative and minimally invasive ART™ system that i |
Inspira Technologies to Present at the Aegis Capital Corp. Virtual ConferenceInspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW), a groundbreaking respiratory support technology company, today announced that Joe Hayon, Inspira's President & Chief Financial Officer will present at the Aegis Virtual Event on February 23, 2022 at 8:30am EST. The presentation can be accessed using this link here. |
Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhDInspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that Daniella Yeheskely-Hayon PhD, an expert in development of artificial lung, has been appointed as its Chief Technology Officer (CTO). |
EV Stocks: What’s Driving LCID, XPEV, RIVN, TSLA, RIDE and WKHS Higher Today?Electric vehicle (EV) stocks are on the rise Monday as several players in the space, including Tesla, see their shares soar higher. |
IINN Price Returns
| 1-mo | N/A |
| 3-mo | -49.61% |
| 6-mo | -68.75% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -68.75% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...